美国 代写：制药工业的道德困境
美国 代写：制药工业的道德困境
制药工业是世界上最大的工业之一，通过他们在各大洲的不断研究和发展，为全世界数百万人提供了大量的药物。他们正在生产治疗危及生命的疾病的药物，并且能够拯救世界各地数百万人的生命。随着他们出色的工作，制药行业面临着许多道德困境。药品价格是许多国家最受欢迎的道德问题之一，而且许多死亡事件的发生仅仅是因为药品价格昂贵，而且患者负担不起。以密歇根州为例，每年有200人死于慢性肝病，这进一步导致每年约1300人死亡(Mack, 2016)。单一肝病导致如此多死亡的主要原因是药物成本。12周的治疗包括Solvadi花费大约84,000美元，而完整的一轮Harvoni花费大约94,500美元。这是一个伦理困境，高价格的药物被认为是如此多的死亡的原因，即使药物制造商知道同样的情况，价格也没有降低。
美国 代写：制药工业的道德困境
上述两种治疗肝病的药物均由吉利德科学公司生产。这就造成了一个道德困境，制药商不得不考虑降低药品价格，以保护那些买不起药的人的爱，同时满足所有者、投资者、股东、利益相关者和员工的期望。该公司正处于一个道德两难的境地，是降低药品价格并承受成本负担(如果有的话)，还是保持现有价格以满足股东和所有者的要求。吉利德科学公司(Gilead Sciences Inc.)正在生产治疗肝病的药物，该公司也清楚肝病的影响，以及由肝病直接和间接导致的死亡人数。他们还意识到，他们的药物价格是病人及其家人感知到的主要因素。
美国 代写：制药工业的道德困境
The pharmaceutical industry is one of the largest industry in the world and providing substantial medications to millions of people around the world with their continuous research and development across continents. They are manufacturing drugs for life threatening diseases and are also able to save millions of lives around the world. Along with the good work they do, there comes a lot of ethical dilemmas facing the pharma industry. The prices of drugs is one of the most sought after ethical issues with many countries and it has also seen a lot of deaths occurring only because of the primary reason of it being expensive and unaffordable to the sufferers of the disease. Citing a case about Michigan, it has been seen that there has been 200 deaths every year due to chronic liver ailments and this further contributes to the death of 1300 people or so on a yearly basis (Mack, 2016). The primary reason identified for so many deaths due to a single disease of liver is the cost of medication. A 12 week treatment involving Solvadi costs around $84,000, whereas the complete round cost of Harvoni costs around $94,500 to the patient. This is an ethical dilemma that high prices of drugs is considered as the reason for such amount of deaths and the prices are not reduced even after the drug manufacturers having the knowledge about the same.
美国 代写：制药工业的道德困境
The two drugs mentioned above for liver ailments are manufactured by the same company, Gilead Sciences Inc. This makes an ethical dilemma that the drug manufacturer is forced to look into the reduction of drug prices to safeguard the loves of the people who are not able to afford the cost of medication, and also to satisfy the owners, investors, shareholders, stakeholders, and employees about their expectations. The company is in an ethical dilemma whether they reduce the drug prices and suffer cost burden, if any, or keep the prices as they are to satisfy their shareholders and owners. The company, Gilead Sciences Inc. is manufacturing the drugs for liver ailments and is also aware of the impacts of the disease and the number of deaths, both direct and indirect, caused by the disease. They are also aware of the prices of their drugs being the primary factor being perceived by the patients and their families.
